Maxim Pharmaceuticals, Inc. v. Crosspoint Venture Partners 1997, L. P.
546 U.S. 819, 126 S. Ct. 348, 163 L. Ed. 2d 58, 74 U.S.L.W. 3202, 2005 U.S. LEXIS 5609
This text of 546 U.S. 819 (Maxim Pharmaceuticals, Inc. v. Crosspoint Venture Partners 1997, L. P.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Maxim Pharmaceuticals, Inc. v. Crosspoint Venture Partners 1997, L. P., 546 U.S. 819, 126 S. Ct. 348, 163 L. Ed. 2d 58, 74 U.S.L.W. 3202, 2005 U.S. LEXIS 5609 (2005).
Opinion
Ct. App. Cal., 4th App. Dist., Div. 1. Certiorari denied.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Bluebook (online)
546 U.S. 819, 126 S. Ct. 348, 163 L. Ed. 2d 58, 74 U.S.L.W. 3202, 2005 U.S. LEXIS 5609, Counsel Stack Legal Research, https://law.counselstack.com/opinion/maxim-pharmaceuticals-inc-v-crosspoint-venture-partners-1997-l-p-scotus-2005.